Janux Therapeutics, Inc.(JANX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

JANX Janux Therapeutics, Inc.

交易中 12-20 14:11:10 EST

57.63

+0.88

+1.55%

最高59.70	最低55.63	成交量41.98万
今开56.37	昨收56.75	日振幅7.17%
总市值33.31亿	流通市值24.99亿	总股本5,780万
成交额2,435万	换手率0.97%	流通股本4,336万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"JANX","market":"US","secType":"STK","nameCN":"Janux Therapeutics, Inc.","latestPrice":57.63,"timestamp":1734721857880,"preClose":56.75,"halted":0,"volume":419768,"delay":0,"floatShares":43364000,"shares":57799500,"eps":-1.186212,"marketStatus":"交易中","marketStatusCode":2,"change":0.88,"latestTime":"12-20 14:11:10 EST","open":56.37,"high":59.7,"low":55.63,"amount":24349460.128296,"amplitude":0.071718,"askPrice":57.82,"askSize":112,"bidPrice":57.45,"bidSize":180,"shortable":3,"etf":0,"ttmEps":-1.186212,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734728400000},"adr":0,"listingDate":1623384000000,"adjPreClose":56.75,"preHourTrading":{"tag":"盘前","latestPrice":57.2,"preClose":56.75,"latestTime":"09:05 EST","volume":364,"amount":20728.029868,"timestamp":1734703509652},"postHourTrading":{"tag":"盘后","latestPrice":57.1,"preClose":56.75,"latestTime":"17:23 EST","volume":10611,"amount":602269.41,"timestamp":1734647013959},"volumeRatio":0.644275,"impliedVol":0.5886,"impliedVolPercentile":0.0357},"requestUrl":"/m/hq/s/JANX/wiki","defaultTab":"wiki","newsList":[{"id":"2489496784","title":"嗡嗡声--美国股票走势-优步、特斯拉、LendingTree","url":"https://stock-news.laohu8.com/highlight/detail?id=2489496784","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489496784?lang=zh_cn&edition=full","pubTime":"2024-12-06 02:42","pubTimestamp":1733424163,"startTime":"0","endTime":"0","summary":".N美东时间13:30，道琼斯工业平均指数.DJI下跌0.37%，报44,843.27点；标准普尔500指数.SPX下跌0.06%，报6,082.73点；纳斯达克综合指数.IXIC下跌0.04%，报19,726.37点。标准普尔 500 指数.PG.INX百分比涨幅前三名是： ** 布朗-福尔曼公司BFb.N，上涨 11.0. ** Protara Therapeutics Inc TARA.OQ，上涨 100.6 纳斯达克.PL.O百分比跌幅前三名： ** Algorhythm Holdings Inc RIME.OQ，下跌 47.7","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241205:nL3T3N61EE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CIVI","HPE","SG9999017495.SGD","HOFT","LU1861559042.SGD","VRNT","APD","LU1316542783.SGD","LUV","CNX","LU0130102774.USD","CSIQ","WTW","DG","TREE","FOUR","COP","TROW","AEO","JBLU","LU2602419157.SGD","TSLA","CTRA","LU1039938227.USD","LU1064131342.USD","UBER","AVAV","LU2125909759.SGD","CRH","GB00BDT5M118.USD","SNPS","SIG","IE00BFMHRM44.USD","JANX","COIN","LU0477156953.USD","CAL","BBW","CLNE","DAL","TARA","GEV","ETR","PDCO","BK4011","LYFT"],"gpt_icon":1},{"id":"2489469559","title":"BUZZ-Janux Therapeutics 募集 3.5 亿美元后创下新纪录","url":"https://stock-news.laohu8.com/highlight/detail?id=2489469559","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489469559?lang=zh_cn&edition=full","pubTime":"2024-12-05 23:59","pubTimestamp":1733414375,"startTime":"0","endTime":"0","summary":"** Janux Therapeutics JANX.O周四股价上涨7%以上，该公司在后续发行中募集的资金超过了预期目标。股价最后上涨 1.4%，报 67.79 美元。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241205:nL3T3N6187:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU0256863902.USD","LU1718418525.SGD","LU0648000940.SGD","IE00BLSP4452.SGD","LU0648001328.SGD","BK4539","LU0321505439.SGD","LU0321505868.SGD","LU1201861165.SGD","LU0306807586.USD","LU0052756011.USD","LU0130103400.USD","LU0170899867.USD","BK4127","SF","LU2129689431.USD","LU0149725797.USD","LU0417517546.SGD","LU1074936037.SGD","LU0320765646.SGD","LU0098860793.USD","LU0128525689.USD","BAC","IE00B19Z3B42.SGD","IE00B1BXHZ80.USD","LU0130102774.USD","LU2129689514.USD","IE00B7SZLL34.SGD","LU1894683348.USD","LU1201861249.SGD","IE00BKVL7J92.USD","LU0208291251.USD","BK4559","IE00BZ1G4Q59.USD","LU1668664300.SGD","LU0971096721.USD","LU1363072403.SGD","LU1894683264.USD","BK4585","BK4139","LU0868494617.USD","LU0306806265.USD","LU0070302665.USD","IE00BBT3K403.USD","LU1496350171.SGD","IE0002270589.USD","JANX","BK4207","LU1791807156.HKD"],"gpt_icon":0},{"id":"2488249239","title":"嗡嗡声--美国股票走势-PSQ Holdings、Core Scientific、Keros","url":"https://stock-news.laohu8.com/highlight/detail?id=2488249239","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488249239?lang=zh_cn&edition=full","pubTime":"2024-12-04 02:41","pubTimestamp":1733251314,"startTime":"0","endTime":"0","summary":"** Credo Technology Group Holding Ltd   : BUZZ - 因第二季度销售额超出预期而大涨   ** Janux Therapeutics Inc   : BUZZ - 因癌症药物的早期数据超出预期而飙升。** Core Scientific Inc   : BUZZ - 在扩大 5.5 亿美元可转换债券发行规模后上涨   ** Keros Therapeutics Inc   : BUZZ - 与武田达成血癌药物许可协议后上涨   ** AT&T Inc   : BUZZ - 在实施扩张计划和提高指导后创下 3 年半新高   ** Rio Tinto PLC   ：** BHP Group Ltd   ：** Southern Copper Corp   ：** Freeport-McMoRan Inc   : BUZZ - 铜矿企业因美元走软而上涨   ** Avadel Pharmaceuticals PLC   : BUZZ - 在首席商务官辞","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXON","DOG","FDN","KR","CORZ","JBGS","UDOW","ZS","CVX","SCCO","AZO",".SPX",".DJI","CHRS","PSQH","TRGP","ROIV","DECK","DJX",".IXIC","XOM","KROS","OLLI","MP","FDX","EQT","DDM","JANX","INTC","LTRN","CUZ","TERN","X","LYV","MOH","CTRN","DXD","T","ADM","CPNG","SDOW","FCX","NEM","AVDL","BLK"],"gpt_icon":1},{"id":"2488942699","title":"嗡嗡声--美国股票走势-贝莱德、Terns Pharma、PSQ Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2488942699","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488942699?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:50","pubTimestamp":1733241022,"startTime":"0","endTime":"0","summary":".N美国东部时间10:30，道琼斯工业平均指数.DJI下跌0.29%，报44,650.91点；标准普尔500指数.SPX下跌0.20%，报6,034.81点；纳斯达克综合指数.IXIC下跌0.10%，报19,384.43点。标准普尔500指数.PG.INX涨幅前三名是： ** Palantir Technologies Inc PLTR.OQ，上涨 5.4. nL3N3N414G  ** Credo Technology Group Holding Ltd CRDO.O:BUZZ - 因第二季度销售额超出预期而大涨 nL3N3N40QR  ** Janux Therapeutics Inc JANX.O:BUZZ - 因癌症药物的早期数据超出预期而飙升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nL3S3N419A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XCUR","CZR","LTRN","PSQH","LU1923622291.USD","KR","LU2430703095.HKD","TCS","TERN","LU2125909759.SGD","MCHP","ZS","OMEX","CPNG","ATIP","CANG","LEV","LYV","AMGN","CTNT","CRDO","JANX","IE00BJJMRZ35.SGD","MP","BK4168","BLK","BK4135","ROIV","NEM","BK4114","AXON","DECK","MPLN","X","BK4187","CTXR","CTRN","CHRS","T","LU1861220033.SGD","IE00B4R5TH58.HKD","AZO","FDX","OLLI","PCG","LU2264538146.SGD"],"gpt_icon":1},{"id":"2488491948","title":"嗡嗡声--美国股票走势-花旗趋势、PG&E、贝莱德","url":"https://stock-news.laohu8.com/highlight/detail?id=2488491948","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488491948?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:05","pubTimestamp":1733234739,"startTime":"0","endTime":"0","summary":"nL3N3N40QR  ** Janux Therapeutics Inc JANX.O:BUZZ - 因癌症药物的早期数据超出预期而飙升。nL3N3N40RX  ** FedEx Corp FDX.N:BUZZ - 伯恩斯坦在发布第二季度财报前将联邦快递的评级下调至 \"市场表现\"。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nL3S3N410V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCG","KR","BK4159","BK4559","ZS","BK4533","IE00BFTCPJ56.SGD","LU1983299246.USD","BLK","LU2264538146.SGD","JANX","BK4535","LU0122379950.USD","CRDO","LU0320765489.SGD","LYV","LU1430597077.USD","LU1861215975.USD","LU1064131342.USD","LU1989771016.USD","ROIV","LU0345770308.USD","IE00B3PB1722.GBP","LU0788109121.HKD","DECK","BK4539","LU0070302665.USD","LU0300736062.USD","AMGN","LU1670627923.USD","X","LU0345770993.USD","CHRS","LU2112291526.USD","CTRN","NEM","LU0109394709.USD","MP","CTNT","FDX","LU1280957306.USD","LU0390134368.USD","AXON","LU0724618789.USD","BK4097","LU0251142724.SGD","BK4170","LU2242652126.USD","LTRN"],"gpt_icon":0},{"id":"2488916743","title":"嗡嗡声--美国股票走势-Zscaler、Credo Technology、联邦快递","url":"https://stock-news.laohu8.com/highlight/detail?id=2488916743","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488916743?lang=zh_cn&edition=full","pubTime":"2024-12-03 20:16","pubTimestamp":1733228212,"startTime":"0","endTime":"0","summary":".N  ** Zscaler Inc ZS.O:BUZZ - 因年度预测低于预期而下滑 nL3N3N40ML  ** Cheetah Net Supply Chain Service Inc CTNT.O:BUZZ - 物流供应商收购竞争对手，股价上涨三倍 nL3N3N40MM   ** 纽蒙特公司 NEM.N： ** 巴里克黄金公司 GOLD.N： ** Gold Fields Ltd GFI.N： ** Harmony Gold Mining Co Ltd HMY.N:BUZZ - 金矿商随着金银价格走高而上涨 nL3N3MY11B  ** United States Steel Corp X.N:BUZZ - 在特朗普重申反对新日铁收购要约后下跌 nL3N3N40OF  ** Kroger Co KR.N:BUZZ - 在杰富瑞将股票评级提升至 \"买入 \"后上涨 nL3N3N40PI  ** Credo Technology Group Holding Ltd CRDO.O:BUZZ - 第二季度销售额超出预期，股价大涨。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9844b7e9879231c84115a6c6d705560f","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nL3T3N40TZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4017","BK4006","LU2125909916.SGD","LU1223082519.USD","BK4168","LU0300736492.USD","KR","CRDO","LU2462611646.USD","BK4532","BK4516","BK4139","LU0345770993.USD","ZS","BK4560","LU0640476718.USD","LU0612318971.USD","LU2125909759.SGD","BK4559","BK4504","BK4533","LU0330918003.SGD","LU0312595415.SGD","LU1267930227.SGD","LU0251142724.SGD","LU0390134368.USD","LU0788109121.HKD","FDX","MP","LU0612318385.USD","CTNT","JANX","LU0345780281.USD","LU1223082196.USD","LU1571399168.USD","X","LU0310800965.SGD","LU0345780521.USD","SG9999001143.SGD","LU0498741114.HKD","LU1430597077.USD","LU1223083913.SGD","LU0048573561.USD","LU1280957306.USD","NEM","BK4570","LU0075056555.USD","LU0266512127.USD","BK4159","LU1023059493.AUD"],"gpt_icon":0},{"id":"2488291372","title":"BUZZ-抗癌药物的早期数据超出预期，Janux 公司业绩大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2488291372","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488291372?lang=zh_cn&edition=full","pubTime":"2024-12-03 19:45","pubTimestamp":1733226335,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"95910b0834a2e3fe5eb6677103425ecd","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nL3S3N40S6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","JANX","BK4139"],"gpt_icon":0},{"id":"1137546102","title":"盘前异动 | 特斯拉跌1.4%，中国销量同比下滑4%；医药公司Janux涨近60%，其前列腺癌药物获得突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1137546102","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137546102?lang=zh_cn&edition=full","pubTime":"2024-12-03 17:24","pubTimestamp":1733217854,"startTime":"0","endTime":"0","summary":"$超微电脑$ 续涨超8%，公司经审查未发现欺诈证据，隔夜已涨近30%。此前超微电脑在声明中表示，经过公司董事会特别委员会和外部律师的审查后，未发现任何不当行为，安永会计师事务所的辞职及其在辞职信中提到的结论未得到审查支持。生物医药公司 $Janux Therapeutics, Inc.$ 盘前涨近60%，其前列腺癌治疗药物因展现出令人鼓舞的有效性和安全性结果而被选入扩大试验。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"72efd440e6195560f0a519d2a0eb096b","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JANX","TSLA"],"gpt_icon":1},{"id":"2488199608","title":"Janux Therapeutics, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488199608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488199608?lang=zh_cn&edition=full","pubTime":"2024-12-02 23:40","pubTimestamp":1733154004,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日23时40分，Janux Therapeutics, Inc.股票出现波动，股价快速跳水5.07%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120223400598e4ee1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120223400598e4ee1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","JANX","BK4539"],"gpt_icon":0},{"id":"2485305297","title":"Janux Therapeutics, Inc.盘中异动 急速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485305297","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485305297?lang=zh_cn&edition=full","pubTime":"2024-11-23 02:27","pubTimestamp":1732300024,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日02时27分，Janux Therapeutics, Inc.股票出现波动，股价快速拉升5.08%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123022704abd7f07e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123022704abd7f07e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","JANX"],"gpt_icon":0},{"id":"2482526779","title":"Janux Therapeutics, Inc.2024财年第三财季实现净利润-28.06百万美元，同比减少142.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482526779","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482526779?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:00","pubTimestamp":1731254426,"startTime":"0","endTime":"0","summary":"11月11日，Janux Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-28.06百万美元，同比减少142.52%；其中营业收入为439000.00美元，同比减少82.58%，每股基本收益为-0.51美元。从资产负债表来看，Janux Therapeutics, Inc.总负债38.92百万美元，其中短期债务1.69百万美元，资产负债比为0.18，流动比率为0.39。机构评级：截至2024年11月11日，当前有10家机构对Janux Therapeutics, Inc.目标价做出预测，其中目标均价为66.10美元，其中最低目标价为25.00美元，最高目标价为100.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000034abb36215&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000034abb36215&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","JANX"],"gpt_icon":0},{"id":"2481534486","title":"Janux Therapeutics, Inc.盘中异动 急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481534486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481534486?lang=zh_cn&edition=full","pubTime":"2024-11-05 01:38","pubTimestamp":1730741934,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日01时38分，Janux Therapeutics, Inc.股票出现异动，股价急速上涨5.00%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大，Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Gri Bio, Inc.较为活跃，换手率分别为375.10%、275.26%、79.71%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、In8Bio, Inc.、Neurogene Inc.，振幅分别为52.25%、45.39%、39.98%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105013854a21599a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105013854a21599a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JANX","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2478594519","title":"Janux Therapeutics, Inc.盘中异动 急速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478594519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478594519?lang=zh_cn&edition=full","pubTime":"2024-10-26 00:44","pubTimestamp":1729874675,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日00时44分，Janux Therapeutics, Inc.股票出现异动，股价急速拉升5.10%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102600443698e3e8d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102600443698e3e8d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","JANX","LENZ","BK4539"],"gpt_icon":0},{"id":"2477308527","title":"美股异动丨Janux Therapeutics盘前涨4% 获董事增持超5千万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477308527","media":"港股那点事","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477308527?lang=zh_cn&edition=full","pubTime":"2024-10-23 17:07","pubTimestamp":1729674420,"startTime":"0","endTime":"0","summary":"Janux Therapeutics(JANX.US)盘前涨4%报54.9美元。根据美国证券交易委员会(SEC)10月22日披露的文件，Janux Therapeutics董事RA CAPITAL MANAGEMENT, L.P.于10月18日以每股平均价44.75美元增持120万股普通股股份，价值约为5,370万美元。(格隆汇)\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2024-10-23/doc-inctpriw0723764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4539","BK4139","LENZ","JANX"],"gpt_icon":0},{"id":"2474740345","title":"Janux Therapeutics, Inc.盘中异动 急速拉升5.21%报46.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474740345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474740345?lang=zh_cn&edition=full","pubTime":"2024-10-09 00:47","pubTimestamp":1728406024,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日00时47分，Janux Therapeutics, Inc.股票出现异动，股价大幅拉升5.21%。截至发稿，该股报46.45美元/股，成交量19.7065万股，换手率0.38%，振幅4.62%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100900470498e3b386&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100900470498e3b386&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","JANX","BK4139"],"gpt_icon":0},{"id":"2458692137","title":"Janux Therapeutics, Inc.2024财年第二财季实现净利润-5.96百万美元，同比增加65.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458692137","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458692137?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:10","pubTimestamp":1723392638,"startTime":"0","endTime":"0","summary":"8月12日，Janux Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-5.96百万美元，同比增加65.96%；其中营业收入为8.90百万美元，同比增加739.62%，每股基本收益为-0.11美元。从资产负债表来看，Janux Therapeutics, Inc.总负债33.74百万美元，其中短期债务1.63百万美元，资产负债比为0.21，流动比率为0.58。机构评级：截至2024年8月12日，当前有8家机构对Janux Therapeutics, Inc.目标价做出预测，其中目标均价为67.25美元，其中最低目标价为42.00美元，最高目标价为100.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081200104195904260&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081200104195904260&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","JANX"],"gpt_icon":0},{"id":"2455861866","title":"Janux Therapeutics, Inc.盘中异动 大幅跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455861866","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455861866?lang=zh_cn&edition=full","pubTime":"2024-07-30 03:45","pubTimestamp":1722282328,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日03时45分，Janux Therapeutics, Inc.股票出现波动，股价大幅跳水5.00%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730034528af94a6ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730034528af94a6ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JANX","LENZ","BK4539","BK4139"],"gpt_icon":0},{"id":"2454372045","title":"Janux Therapeutics, Inc.盘中异动 急速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454372045","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454372045?lang=zh_cn&edition=full","pubTime":"2024-07-27 03:40","pubTimestamp":1722022805,"startTime":"0","endTime":"0","summary":"北京时间2024年07月27日03时40分，Janux Therapeutics, Inc.股票出现异动，股价急速上涨5.12%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240727034005af945e48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240727034005af945e48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","JANX","LENZ"],"gpt_icon":0},{"id":"2454382913","title":"成分股MeiraGTx收涨11.62%，AC Immune涨10.76%，诺瓦瓦克斯医药涨8.25%表现第三，和黄医药则收跌3.","url":"https://stock-news.laohu8.com/highlight/detail?id=2454382913","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454382913?lang=zh_cn&edition=full","pubTime":"2024-07-26 04:45","pubTimestamp":1721940358,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["EWTX","BK4531","LENZ","BK4568","BK4547","NVAX","BK4585","HCM","JANX","BK4135","BK1191","BK4007","BK4139","BK4588","BK4539","BK1588","00013","BK1587","AC"],"gpt_icon":0},{"id":"2451071918","title":"Janux Therapeutics, Inc.盘中异动 早盘大幅拉升5.04%报45.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451071918","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451071918?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:50","pubTimestamp":1721137822,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时50分，Janux Therapeutics, Inc.股票出现波动，股价快速上涨5.04%。截至发稿，该股报45.66美元/股，成交量2.8974万股，换手率0.06%，振幅3.36%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162150229681d31e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162150229681d31e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","JANX","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.januxrx.com","stockEarnings":[{"period":"1week","weight":-0.0772},{"period":"1month","weight":0.1579},{"period":"3month","weight":0.1305},{"period":"6month","weight":0.3855},{"period":"1year","weight":4.9549},{"period":"ytd","weight":4.2889}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":-0.0071},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.0764},{"period":"1year","weight":0.2517},{"period":"ytd","weight":0.2331}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Janux Therapeutics, Inc.于2017年6月27日在特拉华州注册成立。该公司是一家创新的生物制药公司，开发基于该公司专有的肿瘤激活T细胞接合器（TRACTr）平台技术的下一代疗法，以更好地治疗癌症患者。该公司最初的重点是开发一类新的T细胞接合器（TCE），该公司的主要候选产品是针对临床验证的药物靶点设计的。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.085364},{"month":2,"riseRate":0.666667,"avgChangeRate":1.511745},{"month":3,"riseRate":0,"avgChangeRate":-0.221441},{"month":4,"riseRate":0.666667,"avgChangeRate":0.155417},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.057273},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.03282},{"month":7,"riseRate":0.75,"avgChangeRate":0.116412},{"month":8,"riseRate":0.5,"avgChangeRate":-0.033618},{"month":9,"riseRate":0.25,"avgChangeRate":-0.057733},{"month":10,"riseRate":0.75,"avgChangeRate":0.071595},{"month":11,"riseRate":0.25,"avgChangeRate":-0.07955},{"month":12,"riseRate":0.75,"avgChangeRate":0.139891}],"exchange":"NASDAQ","name":"Janux Therapeutics, Inc.","nameEN":"Janux Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Janux Therapeutics, Inc.(JANX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Janux Therapeutics, Inc.(JANX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Janux Therapeutics, Inc.,JANX,Janux Therapeutics, Inc.股票,Janux Therapeutics, Inc.股票老虎,Janux Therapeutics, Inc.股票老虎国际,Janux Therapeutics, Inc.行情,Janux Therapeutics, Inc.股票行情,Janux Therapeutics, Inc.股价,Janux Therapeutics, Inc.股市,Janux Therapeutics, Inc.股票价格,Janux Therapeutics, Inc.股票交易,Janux Therapeutics, Inc.股票购买,Janux Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Janux Therapeutics, Inc.(JANX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Janux Therapeutics, Inc.(JANX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}